1. Home
  2. MIRA

as of 06-24-2026 2:58pm EST

$0.92
$0.03
-3.46%
Stocks Health Care Biotechnology: Pharmaceutical Preparations Nasdaq

Mira Pharmaceuticals Inc is a clinical-stage pharmaceutical development company focused on developing novel oral small-molecule therapeutics for neurologic, neuropsychiatric, metabolic, and inflammatory disorders. The company's pipeline includes three product candidates: Ketamir-2, MIRA-55, and SKNY-1, three drug candidates designed to address unmet medical needs across neuropathic and inflammatory pain, central nervous system disorders, and metabolic and behavioral conditions. The company operates as a single operating and reportable segment.

Founded: 2020 Country:
United States
United States
Employees: N/A City: MIAMI
Market Cap: 43.7M IPO Year: 2023
Target Price: N/A AVG Volume (30 days): 119.2K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -0.03 EPS Growth: -164.71
52 Week Low/High: $0.90 - $2.45 Next Earning Date: 05-13-2026
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A
P/E Ratio: -31.80 Index: N/A
Free Cash Flow: N/A FCF Growth: N/A

Share on Social Networks: